Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access

Herzog, Lisa; Norheim, Ole F.; Emanuel, Ezekiel J.; McCoy, Matthew S.

doi:10.1136/bmj.m4853

Cited by 79 publications

(75 citation statements)

References 2 publications

(1 reference statement)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The World Health Organization is calling for fair allocation to countries in proportion to population size. An alternative prioritisation would focus on reducing harm to health and economies 7. Worldwide shortages of vaccine are inevitable.…”

mentioning

confidence: 99%

Covid 19: Hope is being eclipsed by deep frustration

Godlee¹

2021

BMJ

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Covid 19: Hope is being eclipsed by deep frustration

Godlee¹

2021

BMJ

View full text Add to dashboard Cite

show abstract

“…Some firmly oppose vaccine nationalism, which is neither ethically justified nor is it a valid method for protecting the long-term interests of countries who intend to employ it [ 32 , 33 ]. It is simply an instrument used in political power play [ 34 ], which must be counteracted [ 35 ].…”

Section: Equity and Vaccine Nationalismmentioning

confidence: 99%

“…For example, consider the Fair Priority Model [ 30 , 35 ], which proposed placing the priorities on a scale for inclusion in the COVAX plan. Another equitable vaccine initiative was developed by the US National Academics of Science, Engineering and Medicine at the request of the National Institutes of Health (NIH), and by the Centers for Disease Control and Prevention (CDC) [ 59 ].…”

Section: Supranational Initiatives Based On Equitymentioning

confidence: 99%

COVID-19 Pandemic and Equal Access to Vaccines

et al. 2021

View full text Add to dashboard Cite

The COVID-19 pandemic has evidenced the chronic inequality that exists between populations and communities as regards global healthcare. Vaccination, an appropriate tool for the prevention of infection, should be guaranteed by means of proportionate interventions to defeat such inequality in populations and communities affected by a higher risk of infection. Equitable criteria of justice should be identified and applied with respect to access to vaccination and to the order in which it should be administered. This article analyzes, as regards the worldwide distribution of anti-COVID-19 vaccines, the various ways the principle of equity has been construed and applied or even overlooked. The main obstacle to equal access to vaccines is vaccine nationalism. The perception of equity varies with the differing reference values adopted. Adequate response to needs appears to be the principal rule for achieving the criterion of equity in line with distributive justice. Priorities must be set equitably based on rational parameters in accordance with current needs. The entire process must be governed by transparency, from parameter identification to implementation. The issue of equal access to vaccination affects the entire world population, necessitating specific protective interventions. In light of this, the World Health Organization (WHO) has devised the COVAX plan to ensure that even the poorest nations of the world receive the vaccine; certain initiatives are also supported by the European Union (EU). This pandemic has brought to the fore the need to build a culture of equitable relationships both in each country’s own domain and with the rest of the world.

show abstract

“…After ensuring the cancer patient group as a priority group for vaccination, an inequitable distribution of COVID-19 vaccines should also be maintained, especially in Low and Middle-Income Countries (LMICs). A global system like COVAX is trying to ensure unbiased vaccine distribution in LMICs but only can cover 20% of the populations of recipient countries [108] . To understand more about the implication of COVID-19 on the vulnerable malignancy patients, COVID-19 and Cancer Taskforce commenced the investigation into the current global availability of COVID-19 vaccines and the variety of national strategies for covering cancer patients and health-care workers till March 31, 2021 [109] .…”

Section: Impact Of Covid-19 Vaccines In Cancer Patientsmentioning

confidence: 99%

COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario

Sayed

2021

Cancer Treatment and Research Communications

View full text Add to dashboard Cite

Background Malignancy is one of the prime global causes of mortality. Cancer Patients suffering from SARS-CoV-2 have demonstrated higher rates of severe complications exacerbating towards death. Possible genetic and epigenetic alterations may exist in cancer patients which may be responsible for their increased vulnerability towards COVID-19. Method An exhaustive literature search using ‘COVID-19’, ‘SARS-CoV-2’, ‘Cancer’, ‘Malignancy’, ‘Relationships’, Interlinks’, ‘Genetic’, ‘Epigenetic’, ‘Epidemiological studies’, ‘Clinical Studies’, ‘Vaccination’, ‘Vaccine scenario’ were conducted in PubMed and EMBASE till 2 nd June, 2021 . Result In this narrative review, 17 epidemiological studies were listed which focused on clinical parameters of several malignancy patient cohorts who contracted COVID-19. Besides, genetic and epigenetic alterations seen among cancer patients are also discussed which may plausibly increase their vulnerability to SARS-CoV-2 infection. Also, global vaccination scenario among malignant patients along with the necessity to prioritize them in the vaccination campaigns are also elaborated. Conclusion Genetic and epigenetic modifications present in ACE2, TMPRSS2, IL-6 and several cytokines require more in-depth research to elucidate the shared mechanisms of malignancy and SARS-CoV-2.

show abstract

Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access

Cited by 79 publications

References 2 publications

Covid 19: Hope is being eclipsed by deep frustration

Covid 19: Hope is being eclipsed by deep frustration

COVID-19 Pandemic and Equal Access to Vaccines

COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario

Contact Info

Product

Resources

About